Literature DB >> 3323828

DNA base changes induced following in vivo exposure of unadapted, adapted or ada- Escherichia coli to N-methyl-N'-nitro-N-nitrosoguanidine.

K K Richardson1, R M Crosby, F C Richardson, T R Skopek.   

Abstract

The adaptive response is one of the major repair pathways in Escherichia coli that removes DNA alkylation damage. To investigate the role of the adaptive response in mutagenesis, the E. coli gpt forward mutation assay system was used to determine the mutation spectrum of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) in MNNG-adapted and unadapted GP120 (wild-type) and unadapted PJ5 (ada-5) cells. We observed that 34/37 mutations in the unadapted GP120 cells, 38/40 mutations in the adapted GP120 cells, and 10/10 mutations in the PJ5 cells were GC----AT transitions. The remaining 3/37 mutations in the unadapted GP120 cells were large insertions. The remaining 2/40 mutations in the adapted GP120 cells were transversions with one a GC----CG and the other an AT----CG. A surrounding sequence specificity of mutagenesis was observed for the GC----AT transitions in both the unadapted (GP120 and PJ5) and adapted (GP120) cells, with 70% of the unadapted PJ5, 68% of the unadapted GP120, and 61% of the adapted GP120 mutations occurring at the middle G of the sequence 5'--GG(A or T)--3'. Both strains also displayed a statistically significant preference for mutagenesis at guanine bases in the non-transcribed strand. The overall distribution of mutated sites in the gpt gene in adapted and unadapted cells was similar, although the rate of mutations at certain sites appeared different. These minor differences could result from either non-uniform repair of alkylation damage at different sites on the DNA, or altered processing of the alkylated bases to mutations in the adapted state.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3323828     DOI: 10.1007/BF00331159

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  53 in total

Review 1.  Cellular defence mechanisms against alkylating agents.

Authors:  P Karran; T Lindahl
Journal:  Cancer Surv       Date:  1985

2.  Repair of oligodeoxynucleotides containing O6-methylguanine by O6-alkylguanine-DNA-alkyltransferase.

Authors:  D Scicchitano; R A Jones; S Kuzmich; B Gaffney; D D Lasko; J M Essigmann; A E Pegg
Journal:  Carcinogenesis       Date:  1986-08       Impact factor: 4.944

3.  Dideoxy sequencing method using denatured plasmid templates.

Authors:  M Hattori; Y Sakaki
Journal:  Anal Biochem       Date:  1986-02-01       Impact factor: 3.365

4.  A system for detection of genetic and epigenetic alterations in Escherichia coli induced by DNA-damaging agents.

Authors:  Z Toman; C Dambly-Chaudière; L Tenenbaum; M Radman
Journal:  J Mol Biol       Date:  1985-11-05       Impact factor: 5.469

5.  Repair of O6-methylguanine in adapted Escherichia coli.

Authors:  P F Schendel; P E Robins
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

6.  Induction of a DNA glycosylase for N-methylated purines is part of the adaptive response to alkylating agents.

Authors:  P Karran; T Hjelmgren; T Lindahl
Journal:  Nature       Date:  1982-04-22       Impact factor: 49.962

7.  Adaptation to alkylation resistance involves the induction of a DNA glycosylase.

Authors:  G Evensen; E Seeberg
Journal:  Nature       Date:  1982-04-22       Impact factor: 49.962

8.  Enzymatic repair of O-alkylated thymidine residues in DNA: involvement of a O4-methylthymine-DNA methyltransferase and a O2-methylthymine DNA glycosylase.

Authors:  Z Ahmmed; J Laval
Journal:  Biochem Biophys Res Commun       Date:  1984-04-16       Impact factor: 3.575

9.  Molecular cloning of a gene which regulates the adaptive response to alkylating agents in Escherichia coli.

Authors:  B Sedgwick
Journal:  Mol Gen Genet       Date:  1983

10.  Inducible repair of O-alkylated DNA pyrimidines in Escherichia coli.

Authors:  T V McCarthy; P Karran; T Lindahl
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

View more
  8 in total

1.  Mutagenic specificity of N-methyl-N'-nitro-N-nitrosoguanidine in the gpt gene on a chromosome of Chinese hamster ovary cells and of Escherichia coli cells.

Authors:  H Sockett; S Romac; F Hutchinson
Journal:  Mol Gen Genet       Date:  1991-06

2.  Mutation signatures specific to DNA alkylating agents in yeast and cancers.

Authors:  Natalie Saini; Joan F Sterling; Cynthia J Sakofsky; Camille K Giacobone; Leszek J Klimczak; Adam B Burkholder; Ewa P Malc; Piotr A Mieczkowski; Dmitry A Gordenin
Journal:  Nucleic Acids Res       Date:  2020-04-17       Impact factor: 16.971

3.  Mutation spectra of N-ethyl-N'-nitro-N-nitrosoguanidine and 1-(2-hydroxyethyl)-1-nitrosourea in Escherichia coli.

Authors:  K K Richardson; R M Crosby; T R Skopek
Journal:  Mol Gen Genet       Date:  1988-11

Review 4.  Mechanisms of transcription-repair coupling and mutation frequency decline.

Authors:  C P Selby; A Sancar
Journal:  Microbiol Rev       Date:  1994-09

5.  Binding and repair of O6-ethylguanine in double-stranded oligodeoxynucleotides by recombinant human O6-alkylguanine-DNA alkyltransferase do not exhibit significant dependence on sequence context.

Authors:  K Bender; M Federwisch; U Loggen; P Nehls; M F Rajewsky
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

6.  N-(3-oxohexanoyl)-L-homoserine lactone regulates carbapenem antibiotic production in Erwinia carotovora.

Authors:  N J Bainton; P Stead; S R Chhabra; B W Bycroft; G P Salmond; G S Stewart; P Williams
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

7.  Non-phenotypic selection of N-methyl-N-nitrosourea-induced mutations in human cells.

Authors:  F Palombo; M Bignami; E Dogliotti
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

8.  Sequence specificity of streptozotocin-induced mutations.

Authors:  S L Mack; R J Fram; M G Marinus
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.